Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Eight physician groups sent a letter to U.S. Food and Drug Administration (FDA) Commissioner Stephen Ostroff underscoring the need to ensure that biosimilar product labeling contains all needed data for physicians to make appropriate prescribing ...
read more
EMD Millipore and Singulex have entered into a definitive agreement under which EMD Millipore will control and manage the Singulex Life Science Research business.
read more
The U.S. Food and Drug Administration's (FDA) recent approval of Zarxio (filgrastim-sndz) -- the first biosimilar product approved in the United States -- points toward growth in the contract manufacturing organization (CMO) industry, according to ...
read more
The Drug Enforcement Administration (DEA) raided medical clinics, pharmacies and other locations across the South on Wednesday as part of a DEA attempt to thwart illegal prescription drug sales.
read more
Novartis has announced that the Phase III study of Afinitor® (everolimus) tablets plus best supportive care in patients with advanced nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin met its primary endpoint.
read more
Abbvie has released details of the stock and cash breakdown of its previously announced $21B buyout of Pharmacyclics.
read more
Pharmatek, a CDMO, has completed installation of a GEA Niro Mobile Minor™ for the GMP manufacture of amorphous spray dried dispersions.
read more
WuXi PharmaTech has announced that its toxicology facility in Suzhou recently passed a surveillance Good Laboratory Practice (GLP) inspection by FDA with no major observations.
read more
CPhI Worldwide, organised by UBM EMEA, announces its Expert Panel for CPhI Worldwide 2015 ahead of the eagerly anticipated annual report (3rd edition) – to be released September and October 2015, in three parts. The report presents a holistic ...
read more
Screening for cancer has gotten more complicated in recent years with evolving guidelines that sometimes conflict. Now a doctors' group aims to ease some confusion — and encourage more discussion of testing's pros and cons.
read more
Janssen Pharmaceuticals has announced that the FDA approved under priority review the New Drug Application (NDA) for the three-month long-acting atypical antipsychotic INVEGA TRINZA™.
read more
The FDA is moving to collect more information on antibiotics used in animals that become meat. It's an effort to stem antibiotic-resistant diseases.
read more
HedgePath Pharmaceuticals (HPPI) has entered into a definitive agreement with an affiliate of Mayne Pharma Group Limited under which Mayne Pharma will invest $2.5M in HPPI in a private common stock and warrant financing.
read more
inVentiv Health has announced an expansion of compliance products and services to assist biopharmaceutical companies conducting non-interventional studies (NIS) in any of 52 countries around the world.
read more
Medical device manufacturers hoping to enter the US market face increasing commercial competition and challenges to gain the funding necessary to support emerging brands. Because development and commercialization can consume a lot of resources, many...
read more